WithdrawnNot Applicable

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

Stopped: Never completed this study

United States0Started 2021-08-13

Plain-language summary

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Sign a written Informed Consent Document * Implanted commercially with the LAL and completed LDD light treatments Exclusion Criteria: * Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL

What they're measuring

Manifest refraction

Timeframe: Pre operatively and immediately post operatively

Trial details

NCT IDNCT06488066

SponsorVance Thompson Vision

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-01

View on ClinicalTrials.gov More Cataract trials